Home › Ovarian Epithelial Carcinoma › Massachusetts › Boston
Ovarian Epithelial Carcinoma clinical trials in Boston, MA
8 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Isoquercetin in People With Ovarian Cancer
RecruitingPhase 2
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RecruitingPhase 1
- Site 0104, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
RecruitingPhase 1
- Massachusetts General Hospital, Boston
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecruitingPhase 2
- Massachusetts General Hospital, Boston
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RecruitingObservational study
- Massachusetts General Hospital, Boston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- Dana Farber/Partners Cancer Care Inc, Boston
Ovarian Epithelial Carcinoma trials in other cities
- Durham, NC8 studies
- New York City, NY7 studies
- San Diego, CA7 studies
- Chicago, IL7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Cleveland, OH6 studies
- Houston, TX6 studies
- Salt Lake City, UT5 studies
- Minneapolis, MN5 studies
- Portland, OR5 studies
- Edison, NJ5 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.